You have 9 free searches left this month | for more free features.

City

Anyang-si (1)

Houston (1)

Hwasun (1)

Los Angeles (1)

Saint Louis (1)

Seongnam-si (1)

Seoul (1)

Suwon-si, (1)

Tampa (1)

Condition

Advanced Melanoma (1)

Gastric Cancer (1)

Overall Status

Recruiting (2)

Sign in for free

Phase

phase 2 (2)

Sponsor

Hanmi Pharmaceutical Company Limited (1)

RAPT Therapeutics, Inc. (1)

Collaborator

Merck Sharp & Dohme LLC (1)

Intervention

flx475 (2)

ipilimumab (1)

pembrolizumab (1)

Study Documents

Intervention Type

drug (2)

Funder Type

Industry (2)

Study Type

Interventional (2)

flx475

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Advanced Melanoma Trial in United States (FLX475, Ipilimumab)

Recruiting

Advanced Melanoma

FLX475
Ipilimumab

Los Angeles, California
+3 more

Jun 10, 2022

Gastric Cancer Trial in Korea, Republic of (FLX475, Pembrolizumab)

Recruiting

Gastric Cancer

FLX475
Pembrolizumab

Anyang-si, Gyeonggi-do, Korea, Republic of
+9 more

Apr 27, 2022